Marizomib (Salinosporamide A)

Marizomib (Salinosporamide A) is a novel marine derived proteasome inhibitor which inhibits CT-L β5, C-L β1, and T-L β2 proteasome activities in human erythrocyte-derived 20S proteasomes with IC50 of 3.5 nM, 430 nM, 28 nM.

• Supplier: Selleck Chemicals
• Product #: S7504
• Sku #: S7504-5mg